scRNA-seq analysis showed that aberrant inflammatory transcription of A20 in KCs in psoriasis is related to the IL-17 and tumor necrosis factor-α(TNF-α) signaling pathways (62), suggesting a potential targeted therapy. This evidence concerns the gene IL17A and psoriasis.